報價延遲最少15分鐘:2025/01/21 18:40 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.1253 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.07/--
|
|
企業價值
128.91M
|
| 資產負債 |
|
每股賬面淨值
0.21
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
25.19M
|
|
每股收益
0.02
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 18:40 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment. |